This study aims to evaluate the use of a digital solution, integrated into the electronic health record, for prospective and structured reporting of clinical and patient-reported outcomes for patients diagnosed with localized or locally advanced prostate cancer.
Pathology confirmed diagnosis of localized or locally advanced prostate cancer
Being able to speak, read and understand Dutch, French, or English
Each patient (or their legally acceptable representative) must sign an informed consent form (ICF) indicating that he understands the purpose of, and is willing to participate in the study.
Patients with prior treatment for prostate malignancies will be excluded.
Dementia, mental alteration, or psychiatric pathology that can compromise informed consent from the patient and/ or adherence to the protocol and the monitoring of the trial
Patients who cannot submit themselves to following the protocol for psychological reasons, social, family, or geographical.
Persons deprived of liberty or under guardianship
Universitaire Ziekenhuizen KU Leuven
Lead sponsor
AZ Sint-Jan AV
Collaborator
General Hospital Groeninge
Collaborator
AZ Sint-Blasius Dendermonde
Collaborator